Opinion | The Pandemic Lessons We Clearly Haven’t Learned

Zeynep Tufekci helps me understand the systems-wide failure on Covid — and how we can prepare for the pandemic’s next phase. Produced by ‘The Ezra Klein Show’ I remember thinking, as Covid ravaged the country in December 2020, that at least the holidays the next year would be better. There would be more vaccines, more treatments, more immunity. Instead, we […]

Read more

Vaccine Mandates, Texas, N.F.L.: Your Weekend Briefing

Here’s what you need to know about the week’s top stories. Send any friend a story As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share. By Remy Tumin (Want to get this briefing by email? Here’s the sign-up.) Here are the week’s top stories, and a look ahead. 1. The U.S. […]

Read more

Opinion | The 2021 High School Yearbook of American Politics

Send any friend a story As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share. By Michelle Cottle Ms. Cottle is a member of the editorial board. Well, that was weird. Much of the past 12 months felt as though 2021 came about by looking at the political insanity of 2020 and […]

Read more

Opinion | Grieving Our Old Normal

Supported by Send any friend a story As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share. Video by Lindsay Crouse, Kirby Ferguson and Emily Holzknecht Ms. Crouse is a writer and producer in Opinion. Mr. Ferguson is a documentary filmmaker. Ms. Holzknecht is an associate producer in Opinion. That’s right: We’re all […]

Read more

Deposit Insurance Corp to oppose Shinsei's poison pill against SBI -NHK

FILE PHOTO: The Shinsei Bank logo is pictured at the lobby of the bank in Tokyo, Oct. 22, 2010. REUTERS/Yuriko NakaoTOKYO (Reuters) -Government-owned Deposit Insurance Corp of Japan is planning to vote against Shinsei Bank’s poison pill defence aimed at blocking SBI Holdings Inc’s $1.1 billion bid, public broadcaster NHK reported on Tuesday. How the government votes on the defence […]

Read more

France's Abionyx to buy IRIS Pharma Holding, expand into ophthalmology

(Reuters) -French biopharmaceutical company Abionyx Pharma said on Wednesday it had signed a deal to buy the owner of ophthalmological group IRIS Pharma. Abionyx said it would fully finance the deal, which values IRIS Pharma Holding at 5 million euros ($5.66 million), through a capital hike that aims to raise around the same amount. “Abionyx will have the means to […]

Read more

Corporate transportation firm Gett takes $1 billion SPAC deal route to go public

(Reuters) – Corporate transportation company GT Gettaxi Ltd (Gett) will go public by merging with a blank-check firm in a deal valued at $1 billion, the companies said on Wednesday. Gett offers corporate fleets, ride-hailing services and taxis on its platform to customers such as private equity firm Silver Lake Partners, Singapore state investor Temasek and online travel portal Expedia. […]

Read more

Opinion | Blue States, You’re the Problem

Why do states with democratic majorities fail to live up to their values? Why do states with democratic majorities fail to live up to their values? Supported by Why do states with democratic majorities fail to live up to their values? Send any friend a story As a subscriber, you have 10 gift articles to give each month. Anyone can […]

Read more

US consensus on China: The fine print

When the Senate voted 68 to 32 in June to pass the United States Innovation and Competitiveness Act, a Bill aimed at boosting American innovation to compete with China, the vote margin – overwhelmingly bipartisan by Capitol Hill’s standards – was read as a signal of how countering Beijing had become the rarest of unicorns in Washington. It was an […]

Read more
1 2 3 34